Single peptide Vial strength 5 mg
GHRP-65 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
GHRP-6, explained simply
A synthetic hexapeptide explored for its ability to stimulate pulsatile growth hormone release.
Research area
Ghrelin signalling, endocrinology and metabolism
How it works
Activates the GHS-R1a receptor; early research also explores immune and tissue interactions.
Why it matters
It helps explain how secretagogues may affect the GH–IGF-1 axis without being equivalent to direct hormone administration.
What has been observed
Experimental hormonal responses and preclinical findings have been reported, but body-composition or recovery effects cannot be assumed from them.
Effects and points to consider
Responses may involve several endocrine systems and depend on the research setting. Reported schedules are not prescriptions.
01 / Vial strength 5 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 5 mg GHRP-6 |
|---|---|
| Final volume | 3 mL |
| Concentration | 1.67 mg/mL |
| One U-100 unit | 16.67 mcg in 0.01 mL |
Standard / Gradual Approach (3 mL = ~1.67 mg/mL)
| Week/Phase | Dose per Injection (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mcg | 6 units (0.06 mL) |
| Weeks 3–4 | 200 mcg | 12 units (0.12 mL) |
| Weeks 5–12 | 300 mcg | 18 units (0.18 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.